Diagnosis & Disease Information

Men receive more aggressive treatment for muscle-invasive urinary bladder cancer (UBC) than women in Sweden.

Bladder preservation therapy is associated with decreased overall survival among patients with muscle-invasive bladder cancer (MIBC).

Low-to-moderate levels of arsenic in drinking water were linked to increased risk for bladder cancer.

The American Society of Clinical Oncology endorsed the European Association of Urology’s guideline on bladder cancer.

Incidence of vascular thromboembolic events (VTEs) in urothelial carcinoma treated with gemcitabine and carboplatin may be higher than expected.

The incidence of bladder cancer is increasing, especially for women.

Patients receiving platinum-based chemotherapy were at higher risk of developing thromboembolism.

Genetic mutations that when present in tumor tissue predict benefit from neoadjuvant chemotherapy (NAC) in bladder cancer.